Most acquisition press releases are boring. Last week’s was not.

On March 2, Zoetis — the world’s largest animal health company, with more than $9 billion in annual revenue — announced it would acquire Neogen’s animal genomics business for $160 million. That business includes GeneSeek, the laboratory network behind the Ingenity Beef profiles and GGP genotyping arrays that underpin the genomic EPDs your herd depends on.

The trade press covered it the way they cover most consolidation news: a paragraph on the price, a quote from a corporate communications officer, and a move on. We’re not doing that. Because buried inside a routine deal announcement is a structural shift in who controls the data infrastructure of American beef genetics. That’s a story worth understanding before the ink dries.

This week we break it down two ways: a plain-English explainer for producers who want the bottom line fast, and a detailed analysis for those who want to understand the full picture.

First time reading? Sign up for free here

Envu’s RangeView App Puts Management of Your Herd in Your Hands | Oklahoma Farm Report
Envu's RangeView platform lets ranchers evaluate forage quantity and quality, identify invasive species, and set up grazing rotation alerts — and through a partnership with Ceres Tag, it can also track GPS cattle locations and individual animal performance in near real-time.

Beef.com Launches Infrastructure Blueprint for a Rancher-First Food Economy | Chainwire
Beef.com is building the first dedicated digital infrastructure network for the global beef industry, connecting ranchers directly to pricing, payment, and market settlement for the first time at scale, with a $25M Phase I securitization currently in discussion.

Alberta Beef Producers Announce Intent to Form Traceability Working Group | Sask Now
Following 15 producer meetings and a town hall session, ABP delegates passed a resolution directing the creation of a traceability working group to push back on proposed Canadian federal amendments they say would create significant burdens without producer buy-in.

Proposed State Budget to Fund UT Martin Cattle Outreach and Workforce Facility | WBBJ News
Tennessee Governor Bill Lee's proposed budget includes $4.23 million to develop the UT Martin Cattle Outreach and Workforce (COW) Facility, which will provide hands-on training in embryo transfer, AI, precision livestock agriculture, and ranch management for the next generation of beef producers.

Ag Innovation: Helping Farmers Prepare for What's Next | Farm Forum
This Farm Forum piece covers how ag innovation tools and programs are helping producers get ahead of industry changes — a timely read as technology adoption accelerates across the sector.

Zoetis to Acquire Neogen Corp's Genomics Business | Canadian Cattlemen
Zoetis announced it has entered into a definitive agreement with Neogen Corporation to acquire its animal genomics business for $160 million, folding in the GeneSeek/Igenity portfolio — a leader in U.S. beef genomics — into Zoetis's Precision Animal Health strategy. Expected to close in the second half of 2026.

The Beef Industry Cannot Afford to Treat AI as a Side Project | Drovers
This Drovers opinion piece (paywalled) makes the case that cattle producers and beef companies need to move AI from an afterthought to a core operational strategy — a message that aligns squarely with where the industry is heading.

Anthropic: Labor Market Impacts of AI — A New Measure and Early Evidence | Anthropic
Anthropic introduces a new measure of AI displacement risk called "observed exposure," finding that actual AI coverage remains a fraction of what's theoretically feasible — and critically, while higher-exposure occupations are showing signs of slower projected growth and reduced hiring for entry-level roles, there is no evidence yet of a systematic rise in unemployment. Relevant context for ag operations thinking about workforce and AI adoption.

Project at UC ANR Center in Yuba County Probes Seaweed Additive Effectiveness on Rangelands | YubaNet.com
Scientists are testing whether red seaweed (Asparagopsis taxiformis) mixed into free-choice mineral supplements can reduce methane emissions from grazing cattle — previous controlled studies showed up to 90% reduction, but delivering it consistently on open rangeland is a whole different challenge.

GeneSeek is the laboratory behind the genomic test results most of you have been receiving for years. When you send in a tissue punch or hair sample on a registered bull or replacement heifer and get back a report showing its weaning weight EPD, marbling score, or feed efficiency index, there’s a good chance GeneSeek processed it. The company operates five labs across four continents and serves customers in more than 120 countries. It’s not a product. It’s infrastructure.

Zoetis is the company that makes a significant portion of the vaccines, dewormers, and pharmaceuticals in your vet’s medicine cabinet. The spun out of Pfizer in 2013 and are now the largest dedicated animal health company on Earth. You’ve used their products, even if you may not have known who made them.

The company that tests your cattle’s DNA is now the same company selling you drugs to treat them. Zoetis paid $160 million to own the genomic data platform, and their stated goal is to connect genetic profiles to health predictions — and then sell the products to act on those predictions. Right now, nothing changes for your operationally. GeneSeek will keep running as-is through the close of the deal and into integration.

Not yet, but you should be paying attention. The near-term concerns are twofold: pricing and data access. Genomic testing costs have fallen dramatically over the past decade because multiple companies were competing for your business. Less competition can mean less pressure to keep prices low. And the genomic records your animals have generated are enormously valuable — to breed associations, universities, and your own operation. The question of who controls that data, and on what terms, is worth asking now.

There’s a principle in agriculture that’s old enough to have been said around a cookstove: be careful when your landlord is also your banker. The conflict isn’t always overt. Usually it isn’t. But the structural incentive — to make decisions that serve the combined entity rather than the individual producer — is always there, even when the people involved are acting in good faith. The Zoetis acquisition of GeneSeek is that principle for the genomic age. It deserves an examination without panic, and without naivety.

To understand why the deal matters, you first have to understand what GeneSeek actually is. Most producers think of genomic testing as a product — something you buy, like a mineral supplement or a preg check. It’s not. It’s infrastructure, in the same way that the county courthouse is infrastructure.

GeneSeek, operating under Neogen, has functioned as something close to a neutral third party in the beef genetics ecosystem. The Ingenity Beef profiles assign genomic-enhanced Expected Progeny Differences (GE-EPDs) for traits like weaning weight, marbling, tenderness, and feed efficiency. Their GGP genotyping arrays are the backbone of much of the breed association data that flows into national cattle evaluations. Every time a breed association publishes an EPD, there’s a decent chance GeneSeek’s data is somewhere in the pipeline.

The company generated roughly $90 million in revenue in fiscal year 2025 across five labs on four continents. It is not a niche player. It is, in many respects, the shared infrastructure of American beef genetics.

That infrastructure now belongs to Zoetis.

Zoetis has been telegraphing this move for years. The company’s strategic framework — what it calls Precision Animal Health — is built on a simple but powerful idea: the future of livestock medicine is predictive rather than reactive. Instead of treating a sick animal, you identify which animals are at elevated risk based on their genetics, environment, and history, and you intervene earlier, more precisely, and with the right product.

Genomic data is the essential upstream input for that model. Right now, Zoetis can tell you which vaccine to use and which dewormer to reach for. With GeneSeek, they gain the ability to correlate genomic markers with health outcomes across a massive global dataset. Over time, that means the EPD on a calf tag could inform not just breeding decisions, but herd health protocols — and the Zoetis products deployed to execute them.

Map it as a supply chain: Zoetis tests your animal’s DNA, builds a predictive health profile, identifies elevated risk for respiratory disease or poor feed conversion, recommends an intervention, and sells you the vaccine or pharmaceutical to act on it.

To be clear: there is nothing inherently wrong with vertical integration. It can drive real innovation and lower costs. The dairy sector has operated with deeply integrated input providers for decades. The question is not whether integration is good or bad in the abstract, it’s whether the incentive structures that emerge serve producers or extract value from them.

The more consequential issue is not pricing, it’s data governance. This is where the conversation needs to get specific.

The genomic records accumulated through GeneSeek represent one of the most valuable agricultural datasets in the world. Breed associations have built national evaluation pipelines that depend on access to that data. Land-grant universities have built research programs on it. Third-party analytics platforms have built commercial products around it. USDA research initiatives touch it.

What changes (or doesn’t change) in how that data flows is the most important question coming out of this deal. A privately held platform under a publicly traded company with fiduciary obligations to shareholders operates under different incentives than a cooperatively structured or nonprofit genomic registry. That’s not a criticism of Zoetis, it’s a structural reality that breed associations, universities, and individual producers should be engaging with directly, in conversations with Zoetis, before the deal closes in the second half of 2026.

GeneSeek’s closest competitors now face a rival backed by a $9 billion enterprise with global distribution, an existing customer base in virtually every major cattle market, and the ability to bundle genomic testing into broader animal health packages. That’s not insurmountable, but it’s a meaningful structural shift.

For producers, competition in the genomics market has been a direct financial benefit over the past decade. The cost of a commercial genomic test has fallen from over $100 per head to under $20 in many cases. That compression happened because multiple credible platforms were competing for your business. The question of whether the Zoetis acquisition accelerates or arrests that trend is one nobody can answer yet, but it’s the right one to be tracking.

The Zoetis-GeneSeek deal is not a crisis. It is a consolidation event that concentrates significant power over the data infrastructure of beef genetics in a single, commercially motivated enterprise. That concentration may produce real innovation and genuine producer benefit. It may also produce pricing pressure, data silos, and a shrinking ecosystem of independent tools and research partnerships. Which direction it goes depends in large part on how producers and breed associations engage with it over the next 24 months.

The ranchers who fare best in this new landscape are the ones who ask hard questions now, negotiate data access agreements before they need them, and treat their genomic records the way they treat their land: as an asset worth protecting.

The genomic cattle that built your herd took generations of selection. The data they represent is equally valuable. Don’t wait until someone else has decided what it’s worth.

The Zoetis deal won’t close until the second half of 2026, which means the next few months are the window for producers and breed associations to get in front of it. We’ll be tracking the regulatory review process, any statements from major breed associations about data access terms, and how GeneSeek’s competitors respond strategically.

BeefTech.News – Keeping you ahead of the herd.

If you found this issue useful, forward it to one rancher who should be reading it. If you have questions, information, or strong opinions about the GeneSeek acquisition, reply to this email — we read everything.